Borealis-1: A randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer
Joaquim Bellmunt, B. J. Eigl, E. Senkus, Y. Loriot, P. Twardowski, D. Castellano, N. Blais, S. S. Sridhar, C. N. Sternberg, M. Retz, S. Pal, B. Blumenstein, C. Jacobs, P. S. Stewart, D. P. Petrylak
Research output: Contribution to journal › Article › peer-review
18Scopus
citations
Fingerprint
Dive into the research topics of 'Borealis-1: A randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer'. Together they form a unique fingerprint.